speb/financial-data huggingface dataset:
Stock screener scorecard for 6322.T (annual, report date 2026-03-31)
Altman Z-score: 4.791812931500949 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.66523433009312%
Earnings yield: 0.1318384545861139%
Return on net tangible assets: 11.662411953883304%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.086002460668105%
Free cash flow margin: 6.763743972932473%
Revenue growth: -6.0898932356114015%
Rule of 40 score: 0.6738507373210716
Market cap: 11081975808 (Large Cap ($10B-$200B))
P/E ratio: 0.05478781111905272
Debt to equity: 0.0315
Free cash flow (dilution adjusted): 4720533.033033033
Operating income: 10202946.696696697
Net income: 7703897.647647647
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 8059.T (annual, report date 2026-03-31)
Altman Z-score: 3.3158053016789077 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 18.66919167836074%
Earnings yield: 0.13269040681050023%
Return on net tangible assets: 12.244506393688702%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.217532501219123%
Free cash flow margin: 6.8659304554166285%
Revenue growth: -7.49772455145502%
Rule of 40 score: -0.6317940960383917
Market cap: 110210662400 (Large Cap ($10B-$200B))
P/E ratio: 0.06511691705218298
Debt to equity: 0.07719999999999999
Free cash flow (dilution adjusted): 94131631.63163163
Operating income: 85729479.47947948
Net income: 62593843.84384384
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 9301.T (annual, report date 2026-03-31)
Altman Z-score: 2.5108591461695107 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.954492575104359%
Earnings yield: 0.016337969370985504%
Return on net tangible assets: 21.054915803483595%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.985432707806959%
Free cash flow margin: 2.3884319583971796%
Revenue growth: -9.894092999940241%
Rule of 40 score: -7.505661041543062
Market cap: 551210516480 (Mega Cap (>= $200B))
P/E ratio: 0.053055880557966964
Debt to equity: 0.2988
Free cash flow (dilution adjusted): 40859609.60960961
Operating income: 99649649.64964965
Net income: 344513263.2632633
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9626.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.721749536728627 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 2.0137021834035824%
Earnings yield: 0.056991142878953384%
Return on net tangible assets: 2.1487094724656495%
Capitalized R&D asset: 263382944.32063937
ROCI (R&D adjusted): 0.816543495210433%
Rosenberg metric: -0.2951812614566687
Revenue growth: -9.037117552924789%
Rule of 40 score: -9.037117552924789
Market cap: 56874930176 (Large Cap ($10B-$200B))
P/E ratio: 5.626087644360069
Debt to equity: 0.6129
Operating income: 24132416.78726483
Net income: 30358755.426917512
Long score: 1 | Short score: 10
Recommendation: Neutral
Stock screener scorecard for ABBN.SW (quarterly, report date 2026-06-30)
Altman Z-score: 4.169134617081763 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.6698521726146%
Earnings yield: 1.4061288987502727%
Return on net tangible assets: 24.383191981495756%
Capitalized R&D asset: 891051431.8643537
ROCI (R&D adjusted): 6.08839684923619%
Rosenberg metric: 0.9194379564749938
Free cash flow margin: 9.646437994722955%
Revenue growth: 7.144775490703282%
Rule of 40 score: 16.791213485426237
Market cap: 145181310976 (Large Cap ($10B-$200B))
P/E ratio: 48.70425981537092
Debt to equity: 0.5575
Free cash flow (dilution adjusted): 1128395061.728395
Operating income: 2095061728.3950615
Net income: 1550617283.950617
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for AG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 4.878259716838119 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 5.758457058159494%
Earnings yield: 1.550804872703012%
Return on net tangible assets: 6.599073133228292%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.447827799347954%
Free cash flow margin: 38.5078741958423%
Revenue growth: 1.3474050015348042%
Rule of 40 score: 39.8552791973771
Market cap: 11351761920 (Large Cap ($10B-$200B))
P/E ratio: 25.821270694287946
Debt to equity: 0.0947
Free cash flow (dilution adjusted): 133236690.64748204
Operating income: 169768345.32374102
Net income: 106105035.97122303
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for AMP.MC (annual, report date 2025-12-31)
Altman Z-score: 1.5678235258770914 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.89361968411304%
Earnings yield: 4.8495594657531145%
Return on net tangible assets: -213.690393918452%
Capitalized R&D asset: -5362866.666666667
ROCI (R&D adjusted): 6.749442138893025%
Free cash flow margin: -20.392002356841406%
Revenue growth: -24.143419322213877%
Rule of 40 score: -44.53542167905528
Market cap: 482538304 (Small Cap ($300M-$2B))
P/E ratio: 279.9863189218524
Debt to equity: 0.8813
Free cash flow (dilution adjusted): -67589411.76470588
Operating income: 23250588.23529412
Net income: 1625882.3529411766
Long score: 2 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for ANIP (quarterly, report date 2026-03-31)
Altman Z-score: 1.923564290949137 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.73512108288135%
Earnings yield: 1.9842233929474027%
Return on net tangible assets: 135.75737162803517%
Capitalized R&D asset: 22875190
ROCI (R&D adjusted): 3.118164444641605%
Rosenberg metric: -0.23741946007666584
Free cash flow margin: 15.52248359737558%
Revenue growth: -3.8848862624463694%
Rule of 40 score: 11.637597334929211
Market cap: 1765343104 (Small Cap ($300M-$2B))
P/E ratio: 19.870801033591732
Debt to equity: 1.1208
Free cash flow (dilution adjusted): 36860000
Operating income: 38706000
Net income: 29492000
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for BVI.PA (annual, report date 2025-12-31)
Altman Z-score: 3.2320645017214154 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 47.57970500278776%
Earnings yield: 8.049233204954817%
Return on net tangible assets: -80.24265244221316%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.3171996542783%
Free cash flow margin: 13.294878139304714%
Revenue growth: 17.022035848901883%
Rule of 40 score: 30.316913988206597
Market cap: 11972714496 (Large Cap ($10B-$200B))
P/E ratio: 23.583295913785363
Debt to equity: 1.7599
Free cash flow (dilution adjusted): 1011411764.7058824
Operating income: 1104352941.1764705
Net income: 717058823.5294118
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CPAY (quarterly, report date 2026-03-31)
Altman Z-score: 1.2896865609755581 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 442.3094108750945%
Earnings yield: 1.583567138644341%
Return on net tangible assets: -6.060106322748481%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.408731333689578%
Free cash flow margin: -10.722315138855516%
Revenue growth: 1.0223308920019292%
Rule of 40 score: -9.699984246853587
Market cap: 24221818880 (Large Cap ($10B-$200B))
P/E ratio: 17.41412327947337
Debt to equity: 2.7133999999999996
Free cash flow (dilution adjusted): -135207000
Operating income: 514742000
Net income: 353714000
Long score: 2 | Short score: 12
Recommendation: Short
Stock screener scorecard for CRAFTSMAN.NS (annual, report date 2026-03-31)
Altman Z-score: 4.065826603986215 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.764168095163887%
Earnings yield: 0.03292871221145353%
Return on net tangible assets: -11.020688883550577%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.458055504353664%
Free cash flow margin: -8.328971121952438%
Revenue growth: 28.54471000014078%
Rule of 40 score: 20.21573887818834
Market cap: 242817744896 (Mega Cap (>= $200B))
P/E ratio: 0.4577728355989908
Debt to equity: 1.1101
Free cash flow (dilution adjusted): -70652818.99109793
Operating income: 84339762.61127597
Net income: 40694150.063586265
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CRAFTSMAN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.2181453057449 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.460621711673605%
Earnings yield: 0.009948581435886918%
Return on net tangible assets: 7.717114810634356%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.066012672890937%
Revenue growth: 2.956336870651083%
Rule of 40 score: 2.956336870651083
Market cap: 242817744896 (Mega Cap (>= $200B))
P/E ratio: 0.4577728355989908
Debt to equity: 1.1101
Operating income: 25481136.074607886
Net income: 12337855.023314964
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CXW (quarterly, report date 2026-03-31)
Altman Z-score: 1.3148525486129072 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.7333173497063985%
Earnings yield: 1.6226617388476483%
Return on net tangible assets: 3.4592616464043706%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.2852921069453633%
Free cash flow margin: -2.605050355522515%
Revenue growth: 1.7842448005059999%
Rule of 40 score: -0.820805555016515
Market cap: 3100153344 (Mid Cap ($2B-$10B))
P/E ratio: 15.3739837398374
Debt to equity: 1.0199
Free cash flow (dilution adjusted): -16014000
Operating income: 69999000
Net income: 37916000
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DBI (quarterly, report date 2026-04-30)
Altman Z-score: 0.607951485104316 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.5436700806476342%
Earnings yield: 1.1054983961468523%
Return on net tangible assets: 11.483232894091866%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.1549856030101753%
Free cash flow margin: -5.510160120628995%
Revenue growth: -2.4158163873041762%
Rule of 40 score: -7.925976507933171
Market cap: 277242848 (Micro Cap ($50M-$300M))
P/E ratio: 33.81818181818182
Debt to equity: 4.311
Free cash flow (dilution adjusted): -38370000
Operating income: 16109000
Net income: 3454000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DO2.DE (annual, report date 2026-03-31)
Altman Z-score: 10.854372863636632 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 46.44347325305068%
Earnings yield: 12.100449528802084%
Return on net tangible assets: 41.10198157493608%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 43.794671481791916%
Free cash flow margin: 19.233188409398906%
Revenue growth: 9.761770470706505%
Rule of 40 score: 28.99495888010541
Market cap: 13310350336 (Large Cap ($10B-$200B))
P/E ratio: 16.22919883341911
Debt to equity: 0.1501
Free cash flow (dilution adjusted): 1052497000
Operating income: 1262903000
Net income: 1024071000
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ECOR3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.3119029065847132 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 26.18525414356879%
Earnings yield: 0.5503165464242825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.401823027271498%
Free cash flow margin: 5.660807972253432%
Revenue growth: -21.208499098295075%
Rule of 40 score: -15.547691126041643
Market cap: 5363239936 (Mid Cap ($2B-$10B))
P/E ratio: 1.444511566753136
Debt to equity: 6.2858
Free cash flow (dilution adjusted): 27538593.15589354
Operating income: 155932889.73384032
Net income: -1918250.9505703424
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for EPAM (quarterly, report date 2026-03-31)
Altman Z-score: 3.590580241769736 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 6.507526668386879%
Earnings yield: 2.95935095861885%
Return on net tangible assets: 5.792946097537788%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.0574566615049217%
Free cash flow margin: -7.437961631671763%
Revenue growth: -0.5319179168312556%
Rule of 40 score: -7.969879548503019
Market cap: 4694163968 (Mid Cap ($2B-$10B))
P/E ratio: 19.45402298850575
Debt to equity: 0.0839
Free cash flow (dilution adjusted): -104136000
Operating income: 116768000
Net income: 82521000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for FA (quarterly, report date 2026-03-31)
Altman Z-score: 0.981877627516482 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.8513423873197645%
Earnings yield: 0.6434179066809026%
Return on net tangible assets: -3.695861567027049%
Capitalized R&D asset: 48903500
ROCI (R&D adjusted): 0.9329631595399137%
Rosenberg metric: -0.559574646236289
Free cash flow margin: 7.524642978600782%
Revenue growth: -8.289188294759498%
Rule of 40 score: -0.7645453161587161
Market cap: 3368987392 (Mid Cap ($2B-$10B))
P/E ratio: 235.2
Debt to equity: 1.5975
Free cash flow (dilution adjusted): 28985000
Operating income: 33520000
Net income: 2168000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for INMD (quarterly, report date 2026-03-31)
Altman Z-score: 19.572921433925643 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.6360477148044748%
Earnings yield: 0.7409898492186082%
Return on net tangible assets: 1.7489523677019239%
Capitalized R&D asset: 2213433.2932630153
ROCI (R&D adjusted): 1.4882973457962376%
Rosenberg metric: -5.516794066613519
Free cash flow margin: 15.259031664167185%
Revenue growth: -20.52680210997278%
Rule of 40 score: -5.267770445805596
Market cap: 871983296 (Small Cap ($300M-$2B))
P/E ratio: 10.133333333333333
Debt to equity: 0.0073
Free cash flow (dilution adjusted): 3960443.0379746836
Operating income: 3182278.481012658
Net income: 3658860.759493671
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KOP (quarterly, report date 2026-03-31)
Altman Z-score: 1.397182230810875 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.178370066632496%
Earnings yield: 1.3094905134961123%
Return on net tangible assets: 12.905982905982908%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.5607785530664708%
Free cash flow margin: 6.808697562047001%
Revenue growth: 5.223018257453201%
Rule of 40 score: 12.031715819500203
Market cap: 965822336 (Small Cap ($300M-$2B))
P/E ratio: 10.23872679045093
Debt to equity: 1.8647999999999998
Free cash flow (dilution adjusted): 31000000
Operating income: 25500000
Net income: 7100000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MRVI (quarterly, report date 2026-03-31)
Altman Z-score: 4.8076048566418494 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0.20222219725651883%
Earnings yield: 0.05522439463264045%
Capitalized R&D asset: 7695480
ROCI (R&D adjusted): 0.11332411250511235%
Rosenberg metric: 5.506599788806758
Free cash flow margin: -3.8200404028130084%
Revenue growth: 32.02783459671921%
Rule of 40 score: 28.207794193906203
Market cap: 2493590528 (Mid Cap ($2B-$10B))
Debt to equity: 0.8536
Free cash flow (dilution adjusted): -2515000
Operating income: 720000
Net income: -3733000
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NSLNISP.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.4419806515022989 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.8955910462600567%
Earnings yield: 0.03702719275643304%
Return on net tangible assets: 4.869396185153688%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.4682664651957795%
Revenue growth: 22.69588590019661%
Rule of 40 score: 22.69588590019661
Market cap: 121356386304 (Large Cap ($10B-$200B))
P/E ratio: 1.7514243511289302
Debt to equity: 0.3502
Operating income: 58963543.8745231
Net income: 41533488.76642645
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for NSLNISP.NS (annual, report date 2026-03-31)
Altman Z-score: 0.7783778540657187 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 3.3357372412006474%
Earnings yield: 0.031705839845105555%
Return on net tangible assets: 6.301406268983113%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.969825495791677%
Free cash flow margin: 11.177915540533112%
Revenue growth: 45.438228946195736%
Rule of 40 score: 56.61614448672885
Market cap: 121356386304 (Large Cap ($10B-$200B))
P/E ratio: 1.7514243511289302
Debt to equity: 0.3502
Free cash flow (dilution adjusted): 161601314.11615092
Operating income: 50489614.243323445
Net income: 6222975.837219161
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for RHC.AX (annual, report date 2025-06-30)
Altman Z-score: 1.3859401737330312 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 8.114507303522656%
Earnings yield: 2.578136398934661%
Return on net tangible assets: -29.58436944937833%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.8334527121194455%
Free cash flow margin: 3.9843612970391704%
Revenue growth: 4.633694155915028%
Rule of 40 score: 8.618055452954199
Market cap: 9764101120 (Mid Cap ($2B-$10B))
P/E ratio: 18.627450980392155
Debt to equity: 2.0747999999999998
Free cash flow (dilution adjusted): 460261437.90849674
Operating income: 568954248.366013
Net income: 30261437.90849673
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for SHILPAMED.NS (annual, report date 2026-03-31)
Altman Z-score: 7.218183634165955 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 18.39309916283803%
Earnings yield: 0.031938748690940946%
Return on net tangible assets: -0.39976161972016655%
Capitalized R&D asset: 5014438.460817886
ROCI (R&D adjusted): 11.926603313792377%
Rosenberg metric: 2.100625378646006
Free cash flow margin: -1.8487591544444948%
Revenue growth: 8.441892338355665%
Rule of 40 score: 6.59313318391117
Market cap: 118561701888 (Large Cap ($10B-$200B))
P/E ratio: 0.29615095431228555
Debt to equity: 0.2547
Free cash flow (dilution adjusted): -3015048.7494701142
Operating income: 39838914.79440441
Net income: 25787409.9194574
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SHILPAMED.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.680498610647559 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 5.188838492814889%
Earnings yield: 0.009010173171617066%
Return on net tangible assets: 6.405151545516395%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7112211509859847%
Revenue growth: 1.4659967220886185%
Rule of 40 score: 1.4659967220886185
Market cap: 118561701888 (Large Cap ($10B-$200B))
P/E ratio: 0.29615095431228555
Debt to equity: 0.2547
Operating income: 11238872.40356083
Net income: 11423272.573124206
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SUNB (annual, report date 2026-04-30)
Altman Z-score: 2.5325794393554557 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 13.885528745145475%
Earnings yield: 5.243344998243259%
Return on net tangible assets: 52.99026425591099%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.0196038803557%
Free cash flow margin: 13.483951945490407%
Revenue growth: 3.3639143730886847%
Rule of 40 score: 16.847866318579094
Market cap: 31020730368 (Large Cap ($10B-$200B))
P/E ratio: 24.044444444444444
Debt to equity: 1.4331
Free cash flow (dilution adjusted): 1504000000
Operating income: 2181000000
Net income: 1325000000
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for SUNB (quarterly, report date 2026-04-30)
Altman Z-score: 1.8929036714373673 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.6103011396192777%
Earnings yield: 0.9856815448325248%
Return on net tangible assets: 13.463143254520165%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0715440582053355%
Free cash flow margin: 15.686274509803921%
Revenue growth: 4.436860068259386%
Rule of 40 score: 20.123134578063308
Market cap: 31020730368 (Large Cap ($10B-$200B))
P/E ratio: 24.044444444444444
Debt to equity: 1.4331
Free cash flow (dilution adjusted): 432000000
Operating income: 410000000
Net income: 226000000
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for SYRMA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.2020383538546495 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.527713293659768%
Earnings yield: 0.006623800874943152%
Return on net tangible assets: 5.892023972327245%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.588318339516093%
Revenue growth: 10.249228671946272%
Rule of 40 score: 10.249228671946272
Market cap: 248158765056 (Mega Cap (>= $200B))
P/E ratio: 0.4832218087484212
Debt to equity: 0.1305
Operating income: 16188215.345485374
Net income: 12635756.676557863
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SYRMA.NS (annual, report date 2026-03-31)
Altman Z-score: 6.959280416125977 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.660798260104905%
Earnings yield: 0.01996445984619237%
Return on net tangible assets: 17.320986847397634%
Capitalized R&D asset: 257542.2823305497
ROCI (R&D adjusted): 13.774167383187605%
Rosenberg metric: 104.47978220436451
Free cash flow margin: 1.9117840225654013%
Revenue growth: 15.367555270398721%
Rule of 40 score: 17.279339292964124
Market cap: 248158765056 (Mega Cap (>= $200B))
P/E ratio: 0.4832218087484212
Debt to equity: 0.1305
Free cash flow (dilution adjusted): 9763671.047053836
Operating income: 48792072.91225095
Net income: 36647520.1356507
Long score: 12 | Short score: 0
Recommendation: Long
Stock screener scorecard for 3030.T (annual, report date 2026-02-28)
Altman Z-score: 4.94031716264487 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 17.95494123938802%
Earnings yield: 0.03819670071868513%
Return on net tangible assets: 12.940610166282909%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.899972122311876%
Free cash flow margin: 3.395244174089223%
Revenue growth: 2.766213143048737%
Rule of 40 score: 6.16145731713796
Market cap: 12351515475.999998 (Large Cap ($10B-$200B))
P/E ratio: 20.254097017519694
Debt to equity: 0.381151752872838
Free cash flow (dilution adjusted): 2492281.5347106378
Operating income: 3429276.2735788524
Net income: 3912665.2123700753
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 360.AX (annual, report date 2025-12-31)
Altman Z-score: 8.985819689875836 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.7020059765774342%
Earnings yield: 0.34746344559327114%
Return on net tangible assets: 43.35813219784378%
Capitalized R&D asset: 237485020
ROCI (R&D adjusted): 3.020736058492312%
Rosenberg metric: 0.8993022083469678
Free cash flow margin: 5.24269583497623%
Revenue growth: 31.76368295808164%
Rule of 40 score: 37.00637879305787
Market cap: 5470454897.778523 (Mid Cap ($2B-$10B))
P/E ratio: 36.26852987282887
Debt to equity: 0.5662097624511567
Free cash flow (dilution adjusted): 25662000
Operating income: 18979000
Net income: 150832000
Long score: 9 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 4088.T (annual, report date 2025-03-31)
Altman Z-score: 1.9383688850422096 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 10.84122969398166%
Earnings yield: 0.04899030287387562%
Return on net tangible assets: 9.771493402167042%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.696152628451728%
Free cash flow margin: 2.0537600529402966%
Revenue growth: 6.293239977047982%
Rule of 40 score: 8.347000029988278
Market cap: 419194352742.86 (Mega Cap (>= $200B))
P/E ratio: 8.317678335308148
Debt to equity: 0.7790290914916047
Free cash flow (dilution adjusted): 147687474.93650582
Operating income: 474408501.53722763
Net income: 336839994.65312123
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 9626.HK (annual, report date 2025-12-31)
Altman Z-score: 1.5082778350101134 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.200889523378688%
Earnings yield: 0.3793578225759345%
Return on net tangible assets: 29.735668889521538%
Capitalized R&D asset: 1050366898.1330559
ROCI (R&D adjusted): 2.965488740137559%
Rosenberg metric: 0.7642617459160538
Free cash flow margin: 17.167682128562607%
Revenue growth: 17.95223917707674%
Rule of 40 score: 35.11992130563935
Market cap: 58528911917.737785 (Large Cap ($10B-$200B))
P/E ratio: 49.038451383112616
Debt to equity: 0.6293842717169426
Free cash flow (dilution adjusted): 744286857.1428571
Operating income: 160635857.14285713
Net income: 170504428.57142857
Long score: 9 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ABBN.SW (annual, report date 2025-12-31)
Altman Z-score: 4.361516048838639 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 39.202134939099494%
Earnings yield: 4.8672095159452295%
Return on net tangible assets: 90.58338022885012%
Capitalized R&D asset: 3129702843.0781593
ROCI (R&D adjusted): 18.825002033440892%
Rosenberg metric: 2.7904104939504055
Free cash flow margin: 13.449729078868152%
Revenue growth: 23.747080470369692%
Rule of 40 score: 37.19680954923784
Market cap: 105909774282.28001 (Large Cap ($10B-$200B))
P/E ratio: 21.95931459304997
Debt to equity: 0.5460771356482038
Free cash flow (dilution adjusted): 5655696202.531646
Operating income: 7251898734.177215
Net income: 6105063291.13924
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ACCO (annual, report date 2025-12-31)
Altman Z-score: 0.6901955094226876 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 21.34316460741331%
Earnings yield: 8.715598791030727%
Return on net tangible assets: -18.833202819107285%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.990938076858534%
Free cash flow margin: 2.5775562405719157%
Revenue growth: -8.492377865802425%
Rule of 40 score: -5.914821625230509
Market cap: 329360324.58 (Small Cap ($300M-$2B))
P/E ratio: 7.974826261016949
Debt to equity: 1.3854950346072825
Free cash flow (dilution adjusted): 39300000
Operating income: 107100000
Net income: 41300000
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for AG.TO (annual, report date 2025-12-31)
Altman Z-score: 4.987214802396063 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.773413021660312%
Earnings yield: 2.3332554657751228%
Return on net tangible assets: 14.801747914255861%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.26131976761755%
Free cash flow margin: 23.531071637749307%
Revenue growth: 134.29607948576697%
Rule of 40 score: 157.82715112351627
Market cap: 11292510020.160002 (Large Cap ($10B-$200B))
P/E ratio: 53.52534670060434
Debt to equity: 0.09730328027467043
Free cash flow (dilution adjusted): 217302919.70802918
Operating income: 255424087.59124085
Net income: 153996350.3649635
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for ANIP (annual, report date 2025-12-31)
Altman Z-score: 2.369582458867084 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 15.113092369776792%
Earnings yield: 4.164172640136349%
Return on net tangible assets: -12162.168486739469%
Capitalized R&D asset: 92847650
ROCI (R&D adjusted): 7.121565276763536%
Rosenberg metric: 3.9902649110607658
Free cash flow margin: 12.789149684275827%
Revenue growth: 43.782634738336135%
Rule of 40 score: 56.57178442261196
Market cap: 1794670744.9199998 (Small Cap ($300M-$2B))
P/E ratio: 22.909617995583183
Debt to equity: 1.141127451343014
Free cash flow (dilution adjusted): 112975000
Operating income: 81230000
Net income: 78337000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CPAY (annual, report date 2025-12-31)
Altman Z-score: 1.4765036505277753 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1405.490628127858%
Earnings yield: 6.0047184198327335%
Return on net tangible assets: -18.276516917154943%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.115706300595683%
Free cash flow margin: 26.42229501217096%
Revenue growth: 13.933868382366077%
Rule of 40 score: 40.356163394537035
Market cap: 19669362284.670002 (Large Cap ($10B-$200B))
P/E ratio: 18.3491757852713
Debt to equity: 2.36520476735395
Free cash flow (dilution adjusted): 1196508000
Operating income: 1951847000
Net income: 1071948000
Long score: 9 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CXW (annual, report date 2025-12-31)
Altman Z-score: 1.5506162411150899 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.766752050343054%
Earnings yield: 5.103784516640921%
Return on net tangible assets: 7.5465990608164555%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.623926154545099%
Free cash flow margin: 1.189182979962753%
Revenue growth: 12.720745741076628%
Rule of 40 score: 13.909928721039382
Market cap: 1889758470.6 (Small Cap ($300M-$2B))
P/E ratio: 16.220685051887074
Debt to equity: 0.9615021964078964
Free cash flow (dilution adjusted): 26295000
Operating income: 220169000
Net income: 116503000
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DBI (annual, report date 2026-01-31)
Altman Z-score: 1.7686639509617155 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.080554186789185%
Earnings yield: 2.8244458060845488%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.028122537539758%
Free cash flow margin: 2.04879849799718%
Revenue growth: -3.874405086695675%
Rule of 40 score: -1.825606588698495
Market cap: 268166275.58 (Micro Cap ($50M-$300M))
Debt to equity: 4.194669168751737
Free cash flow (dilution adjusted): 59265000
Operating income: 41157000
Net income: -5571000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for DTI (annual, report date 2025-12-31)
Altman Z-score: 1.5072775420829065 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.687195200570349%
Earnings yield: 5.6860281654506375%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.607521908852901%
Free cash flow margin: -2.7445403630987433%
Revenue growth: 3.353923054012405%
Rule of 40 score: 0.6093826909136619
Market cap: 86090780.30000001 (Micro Cap ($50M-$300M))
Debt to equity: 0.5830817185223768
Free cash flow (dilution adjusted): -4381000
Operating income: 8817000
Net income: -3761000
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ECOR3.SA (annual, report date 2025-12-31)
Altman Z-score: 0.8626823459909266 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 145.51479785643033%
Earnings yield: 2.6042151726564424%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.158599824085599%
Free cash flow margin: -15.402280672989399%
Revenue growth: 31.607104237554275%
Rule of 40 score: 16.204823564564876
Market cap: 6994377762.094364 (Mid Cap ($2B-$10B))
P/E ratio: 7.895659385262718
Debt to equity: 6.09383581184694
Free cash flow (dilution adjusted): -323815328.46715325
Operating income: 737907664.2335765
Net income: 161651642.3357664
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for EPAM (annual, report date 2025-12-31)
Altman Z-score: 7.737732051888494 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 27.745212911267053%
Earnings yield: 13.178879286574041%
Return on net tangible assets: 24.34453874517251%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.247829279266195%
Free cash flow margin: 7.988318243389843%
Revenue growth: 15.421430898023242%
Rule of 40 score: 23.409749141413087
Market cap: 10703843120.88 (Large Cap ($10B-$200B))
P/E ratio: 28.341187786633057
Debt to equity: 0.039073274080648035
Free cash flow (dilution adjusted): 435927000
Operating income: 520003000
Net income: 377678000
Long score: 14 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FA (annual, report date 2025-12-31)
Altman Z-score: 1.1506665577242283 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.756758242513364%
Earnings yield: 2.5427292142662834%
Capitalized R&D asset: 160867180
ROCI (R&D adjusted): 4.321667996409985%
Rosenberg metric: 4.822993873105912
Free cash flow margin: 7.39448763933183%
Revenue growth: 83.02486035305537%
Rule of 40 score: 90.4193479923872
Market cap: 2492433292.91 (Mid Cap ($2B-$10B))
Debt to equity: 1.5904448396409125
Free cash flow (dilution adjusted): 116418000
Operating income: 132468000
Net income: -34824000
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GRE.MC (annual, report date 2024-12-31)
Altman Z-score: 0.9458987211942529 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 10.763907139728428%
Earnings yield: 2.7653855614982383%
Return on net tangible assets: -48.07237520152927%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.80182112682222%
Free cash flow margin: -56.0724632228451%
Revenue growth: 178.195284108988%
Rule of 40 score: 122.1228208861429
Market cap: 918034546.5999999 (Small Cap ($300M-$2B))
P/E ratio: 15.34738530183727
Debt to equity: 2.1318396350927578
Free cash flow (dilution adjusted): -310489583.3333334
Operating income: 115190625
Net income: 62309375
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for INMD (annual, report date 2025-12-31)
Altman Z-score: 22.960276354367718 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 13.367827788649707%
Earnings yield: 6.252284214891094%
Return on net tangible assets: 13.693541257439279%
Capitalized R&D asset: 7822272.6584786195
ROCI (R&D adjusted): 12.007957734348876%
Rosenberg metric: 1.2871279591992066
Free cash flow margin: 19.74493582909351%
Revenue growth: 7.708791131243618%
Rule of 40 score: 27.45372696033713
Market cap: 2685168279.3624 (Mid Cap ($2B-$10B))
P/E ratio: 28.617069831531158
Debt to equity: 0.012041897078153039
Free cash flow (dilution adjusted): 23004402.51572327
Operating income: 26851257.86163522
Net income: 29506603.773584906
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for KOP (annual, report date 2025-12-31)
Altman Z-score: 2.2976928705634276 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 18.345323741007196%
Earnings yield: 11.261618416066566%
Return on net tangible assets: 54.097171863669324%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.213231306862685%
Free cash flow margin: 2.8574469217261744%
Revenue growth: -10.1715979159696%
Rule of 40 score: -7.314150994243427
Market cap: 518490028.96000004 (Small Cap ($300M-$2B))
P/E ratio: 9.258750517142857
Debt to equity: 1.7804283475535434
Free cash flow (dilution adjusted): 53700000
Operating income: 219300000
Net income: 56000000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FONR (annual, report date 2025-06-30)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.387251411271262%
Earnings yield: 11.355198884909619%
Return on net tangible assets: 7.003570424922769%
Capitalized R&D asset: 3256529
ROCI (R&D adjusted): 5.687671558970318%
Rosenberg metric: -1.2851984706923993
Free cash flow margin: 7.1374048193622235%
Revenue growth: 1.4260990346136029%
Rule of 40 score: 8.563503853975826
Market cap:  (Unknown)
Debt to equity: 0.24308069311179153
Free cash flow (dilution adjusted): 7447976
Operating income: 11598757
Net income: 10673433
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 1065.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.010898053934565 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 5.0039948302635%
Earnings yield: 0.45890249000844513%
Return on net tangible assets: 29.875668732602566%
Capitalized R&D asset: 3838337.619267108
ROCI (R&D adjusted): 1.8260788323280424%
Rosenberg metric: -4.387229879918042
Free cash flow margin: -21.601326404903876%
Revenue growth: -11.355093631087469%
Rule of 40 score: -32.95642003599134
Market cap: 5998996992 (Mid Cap ($2B-$10B))
P/E ratio: 0.7731554160125588
Debt to equity: 0.8672
Free cash flow (dilution adjusted): -35915901.26483358
Operating income: 59735219.35166426
Net income: 42037067.79884226
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 1807.T (annual, report date 2026-03-31)
Altman Z-score: 2.947090049116915 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 5.266416859964786%
Earnings yield: 0.13000700369783685%
Return on net tangible assets: 5.0599708861946455%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.168041304671088%
Free cash flow margin: 14.0126286609776%
Revenue growth: -21.950670188897487%
Rule of 40 score: -7.9380415279198875
Market cap: 11426441216 (Large Cap ($10B-$200B))
P/E ratio: 0.08825190624117482
Debt to equity: 0.0008
Free cash flow (dilution adjusted): 29547816.566566568
Operating income: 6697059.559559559
Net income: 5642542.542542542
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 3RB0.DE (annual, report date 2025-12-31)
Altman Z-score: 3.5652987189909875 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 229.47086403214993%
Earnings yield: 10.434634871567676%
Return on net tangible assets: -39.342839429634225%
Capitalized R&D asset: 839986678.9257612
ROCI (R&D adjusted): 18.021578610556794%
Rosenberg metric: 2.2740124740124745
Free cash flow margin: 11.129883843717%
Revenue growth: 8.382784647870398%
Rule of 40 score: 19.512668491587398
Market cap: 37150715904 (Large Cap ($10B-$200B))
P/E ratio: 13.951048951048952
Debt to equity: 1.0956000000000001
Free cash flow (dilution adjusted): 2136486486.4864864
Operating income: 4629729729.72973
Net income: 4306756756.756757
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 4761.T (annual, report date 2026-03-31)
Altman Z-score: 3.93921981131678 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 11.209580838323355%
Earnings yield: 0.07904825107767542%
Return on net tangible assets: 7.125867676326392%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.3581197355312025%
Free cash flow margin: 0.8575031525851197%
Revenue growth: -1.1896319712355539%
Rule of 40 score: -0.3321288186504342
Market cap: 16122927104 (Large Cap ($10B-$200B))
P/E ratio: 0.07321577227332557
Debt to equity: 0.037000000000000005
Free cash flow (dilution adjusted): 1276276.2762762762
Operating income: 8783783.783783784
Net income: 7657657.657657658
Long score: 9 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4886.T (annual, report date 2026-03-31)
Altman Z-score: 3.079750714553596 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.993661887387155%
Earnings yield: 0.0519948476404686%
Return on net tangible assets: 10.894454382826474%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.475890240653584%
Free cash flow margin: 4.820954068075414%
Revenue growth: 3.804573021235264%
Rule of 40 score: 8.625527089310678
Market cap: 63323332608 (Large Cap ($10B-$200B))
P/E ratio: 0.07725793922225296
Debt to equity: 0.14880000000000002
Free cash flow (dilution adjusted): 21452702.7027027
Operating income: 36498998.998999
Net income: 35191441.44144144
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 7213.T (annual, report date 2026-03-31)
Altman Z-score: 2.72164063174748 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.919303801496365%
Earnings yield: 0.12271687292616962%
Return on net tangible assets: 13.039853532239706%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.577620269087413%
Free cash flow margin: 12.679366444679358%
Revenue growth: -13.734849136377186%
Rule of 40 score: -1.0554826916978275
Market cap: 9499175936 (Mid Cap ($2B-$10B))
P/E ratio: 0.037790017480793164
Debt to equity: 0.1232
Free cash flow (dilution adjusted): 18957344.844844844
Operating income: 7937543.793793794
Net income: 7369494.494494494
Long score: 8 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8091.T (annual, report date 2026-03-31)
Altman Z-score: 2.518692878923772 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 7.646455404918351%
Earnings yield: 0.03600982430428567%
Return on net tangible assets: 7.094594594594595%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.972953479985575%
Free cash flow margin: -1.8736720108170755%
Revenue growth: -2.284033566800554%
Rule of 40 score: -4.157705577617629
Market cap: 19516798976 (Large Cap ($10B-$200B))
P/E ratio: 0.06009064641549844
Debt to equity: 1.0287
Free cash flow (dilution adjusted): -16385135.135135135
Operating income: 17254754.754754756
Net income: 13669919.91991992
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for AFISH.OL (quarterly, report date 2025-12-31)
Altman Z-score: 4.9395520298076585 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 3.579028387739394%
Earnings yield: 0.6238760208568959%
Return on net tangible assets: 1.2135093766173704%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3279306207506263%
Free cash flow margin: 18.559707586421435%
Revenue growth: 104.52558226409027%
Rule of 40 score: 123.08528985051171
Market cap: 1278140672 (Small Cap ($300M-$2B))
P/E ratio: 279.5952127255138
Debt to equity: 1.5399224845630348
Free cash flow (dilution adjusted): 474925.37313432834
Operating income: 786567.1641791044
Net income: 128258.70646766169
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ALPA4.SA (quarterly, report date 2026-03-31)
Altman Z-score: 2.248886517175847 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.557117388806311%
Earnings yield: 0.5245769477315032%
Return on net tangible assets: 6.531272052089224%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.2615836726526135%
Free cash flow margin: 18.952466936703917%
Revenue growth: 2.0437945432082087%
Rule of 40 score: 20.996261479912125
Market cap: 8034966016 (Mid Cap ($2B-$10B))
P/E ratio: 2.741179591475816
Debt to equity: 0.4121
Free cash flow (dilution adjusted): 44299049.429657795
Operating income: 45388821.482889734
Net income: 30952281.368821293
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ARG.TO (quarterly, report date 2026-03-31)
Altman Z-score: 9.014919442927326 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 17.113826171901874%
Earnings yield: 1.5264130599338384%
Return on net tangible assets: 12.87784999484164%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.594734138710816%
Free cash flow margin: 33.83363669819672%
Revenue growth: -15.220140241052308%
Rule of 40 score: 18.613496457144414
Market cap: 1226988288 (Small Cap ($300M-$2B))
P/E ratio: 9.002029145914038
Debt to equity: 0
Free cash flow (dilution adjusted): 24471942.446043167
Operating income: 17897122.302158274
Net income: 10587050.35971223
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for AROC (quarterly, report date 2026-03-31)
Altman Z-score: 0.8237911166924585 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 3.483872970066278%
Earnings yield: 1.5193060034623027%
Return on net tangible assets: 9.847871720582015%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.1768888995484987%
Free cash flow margin: 16.813950937348668%
Revenue growth: -0.8767533077149516%
Rule of 40 score: 15.937197629633717
Market cap: 6333954048 (Mid Cap ($2B-$10B))
P/E ratio: 19.994219653179194
Debt to equity: 1.5737
Free cash flow (dilution adjusted): 62845000
Operating income: 132458000
Net income: 73794000
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for DOCN (quarterly, report date 2026-03-31)
Altman Z-score: 5.41978601039137 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 2.6506871158529512%
Earnings yield: 0.2677262650120561%
Return on net tangible assets: 11.260833418747936%
Capitalized R&D asset: 91066150
ROCI (R&D adjusted): 2.0681907423867387%
Rosenberg metric: 0.05512380263871317
Free cash flow margin: -12.456136949652004%
Revenue growth: 6.400841618878666%
Rule of 40 score: -6.055295330773338
Market cap: 14442826752 (Large Cap ($10B-$200B))
P/E ratio: 37.45851528384279
Debt to equity: 1.6994999999999998
Free cash flow (dilution adjusted): -32125000
Operating income: 36571000
Net income: 15771000
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for EVK.DE (quarterly, report date 2026-03-31)
Altman Z-score: 1.3632265360181939 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.6057142857142854%
Earnings yield: 2.3310213255516654%
Return on net tangible assets: 4.633204633204634%
Capitalized R&D asset: 229998918.18796486
ROCI (R&D adjusted): 1.4590285262838398%
Rosenberg metric: 1.5061935051891528
Free cash flow margin: 5.339947475926466%
Revenue growth: -1.6098033851132103%
Rule of 40 score: 3.7301440908132557
Market cap: 7968600064 (Mid Cap ($2B-$10B))
P/E ratio: 53.245436105476664
Debt to equity: 0.4636
Free cash flow (dilution adjusted): 210344827.58620688
Operating income: 262068965.5172414
Net income: 148275862.06896552
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for INFY (annual, report date 2026-03-31)
Altman Z-score: 377.3143055449025 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 54.86381322957198%
Earnings yield: 0.04933453481050355%
Return on net tangible assets: 43.38611449451889%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 37.41079597438243%
Free cash flow margin: 17.9829348149618%
Revenue growth: -5.20415390244582%
Rule of 40 score: 12.77878091251598
Market cap: 43606958080 (Large Cap ($10B-$200B))
P/E ratio: 16.525
Debt to equity: 0.0983
Free cash flow (dilution adjusted): 38416701.992369644
Operating income: 43334039.84739296
Net income: 35142009.32598559
Long score: 13 | Short score: 1
Recommendation: Long
Stock screener scorecard for INFY (quarterly, report date 2026-06-30)
Altman Z-score: 383.7002931691221 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 15.574604097050706%
Earnings yield: 0.012875204068529163%
Return on net tangible assets: 10.822225155074568%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.952650635966949%
Revenue growth: 0.37591869747159357%
Rule of 40 score: 0.37591869747159357
Market cap: 44996870144 (Large Cap ($10B-$200B))
P/E ratio: 12.950617283950617
Debt to equity: 0.09539999999999998
Operating income: 11309209.832260786
Net income: 8650701.550796498
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NATR (quarterly, report date 2026-03-31)
Altman Z-score: 3.798579800309448 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.002767121564681%
Earnings yield: 3.2512060629049273%
Return on net tangible assets: 3.5119461285916267%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.021252867032805%
Free cash flow margin: -4.853855417765192%
Revenue growth: -0.7390535268603552%
Rule of 40 score: -5.592908944625547
Market cap: 358731392 (Small Cap ($300M-$2B))
P/E ratio: 21.809090909090905
Debt to equity: 0.1344
Free cash flow (dilution adjusted): -5965000
Operating income: 9545000
Net income: 5118000
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for NEC.AX (annual, report date 2025-06-30)
Altman Z-score: 1.0512009716681834 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 21.681638775297937%
Earnings yield: 3.227171438642544%
Return on net tangible assets: -30.548864477595515%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.611279270702365%
Free cash flow margin: 9.137771985743925%
Revenue growth: 0.17424168606600016%
Rule of 40 score: 9.312013671809925
Market cap: 1490616448 (Small Cap ($300M-$2B))
P/E ratio: 9.990662931839402
Debt to equity: 0.166
Free cash flow (dilution adjusted): 159849673.20261437
Operating income: 51773202.614379086
Net income: 87149019.60784313
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for PVP.NS (annual, report date 2026-03-31)
Altman Z-score: 1.2633316384374167 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.378238094853755%
Earnings yield: 0.005035186658264072%
Return on net tangible assets: -840.8385800601975%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8955991366106129%
Free cash flow margin: -160.13840012752073%
Revenue growth: 198.95439079922247%
Rule of 40 score: 38.81599067170174
Market cap: 7111624192 (Mid Cap ($2B-$10B))
Debt to equity: 0.6323
Free cash flow (dilution adjusted): -15224841.034336584
Operating income: 632365.4090716406
Net income: -720474.7774480712
Long score: 1 | Short score: 9
Recommendation: Short